TG Therapeutics | TGTX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 384.69B 19.14B 2026-03
Alaunos Therapeutics USD 7M 2M 2026-03
Amgen USD 189.89B 13.64B 2026-03
Ardelyx USD 1.48B 63M 2026-03
Arrowhead Research USD 8.78B 236M 2026-03
Bayer EUR 38.69B 2.33B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Corcept Therapeutics USD 4.32B 654M 2026-03
Curis USD 12M 10M 2026-07
Gilead Sciences USD 172.99B 20.71B 2026-03
J&J USD 579.15B 78.91B 2026-03
Karyopharm Therapeutics USD 1.12B 989M 2026-07
Novartis USD 307.76B 15.54B 2026-03
Novavax USD 1.09B 316M 2025-12
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
TG Therapeutics USD 5.31B 572M 2026-03
Verastem USD 97M 499M 2026-07
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03